This document is an excerpt from the EUR-Lex website
Document 62017TN0157
Case T-157/17: Action brought on 10 March 2017 — Cristalfarma v EUIPO — Novartis (ILLUMINA)
Case T-157/17: Action brought on 10 March 2017 — Cristalfarma v EUIPO — Novartis (ILLUMINA)
Case T-157/17: Action brought on 10 March 2017 — Cristalfarma v EUIPO — Novartis (ILLUMINA)
IO C 129, 24.4.2017, pp. 37–38
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
24.4.2017 |
EN |
Official Journal of the European Union |
C 129/37 |
Action brought on 10 March 2017 — Cristalfarma v EUIPO — Novartis (ILLUMINA)
(Case T-157/17)
(2017/C 129/57)
Language in which the application was lodged: English
Parties
Applicant: Cristalfarma Srl (Milan, Italy) (represented by: R. Almaraz Palmero, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Novartis AG (Basel, Switzerland)
Details of the proceedings before EUIPO
Applicant: Applicant
Trade mark at issue: EU word mark ‘ILLUMINA’ — Application for registration No 11 934 239
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 11 January 2017 in Case R 1187/2016-4
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO and the other party, should it intervene, to pay the costs of proceedings, including those incurred before the Board of Appeal. |
Pleas in law
|
— |
Infringement of Article 8(1)(b) of Regulation No 207/2009; |
|
— |
Infringement of Articles 75, 42(2) and 64(1) of Regulation No 207/2009. |